(1R)-1-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-2-[[(1S)-2-hydroxy-1-phenylethyl]amino]ethanol
Rif. TR-D447075
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
2500µg | Fuori produzione |
Informazioni sul prodotto
- (alphaR)-alpha-[[[(1S)-2-Hydroxy-1-phenylethyl]amino]methyl]-2,2-dimethyl-4H-1,3-benzodioxin-6-methanol
Applications (αR)-α-[[[(1S)-2-Hydroxy-1-phenylethyl]amino]methyl]-2,2-dimethyl-4H-1,3-benzodioxin-6-methanol is an intermediate in the synthesis of Vilanterol Trifenatate-d4 (V260002). Vilanterol Trifenatate (V260000) is a long-acting β2 adrenergic receptor Agonist. It demonstrates prolonged bronchodilation in subjects with asthma and COPD.
References Procopiou, P., et al.: J. Med. Chem., 53, 4522 (2010); Kempsford, R., et al.: Pulm. Pharmacol. Ther., 26,